Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Short-term Investments (2021 - 2025)

InspireMD filings provide 5 years of Short-term Investments readings, the most recent being $45.3 million for Q4 2025.

  • On a quarterly basis, Short-term Investments rose 187.97% to $45.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $45.3 million, a 187.97% increase, with the full-year FY2025 number at $45.3 million, up 187.97% from a year prior.
  • Short-term Investments hit $45.3 million in Q4 2025 for InspireMD, up from $7.9 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $45.3 million in Q4 2025 to a low of $7.9 million in Q2 2025.
  • Median Short-term Investments over the past 5 years was $22.0 million (2021), compared with a mean of $21.5 million.
  • Biggest five-year swings in Short-term Investments: plummeted 60.74% in 2023 and later surged 187.97% in 2025.
  • InspireMD's Short-term Investments stood at $22.0 million in 2021, then plummeted by 40.23% to $13.2 million in 2022, then surged by 123.09% to $29.4 million in 2023, then plummeted by 46.5% to $15.7 million in 2024, then surged by 187.97% to $45.3 million in 2025.
  • The last three reported values for Short-term Investments were $45.3 million (Q4 2025), $7.9 million (Q2 2025), and $13.7 million (Q1 2025) per Business Quant data.